Literature DB >> 26958036

Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.

Barbra Katusiime1, Daniel Semakula2, Solomon J Lubinga3.   

Abstract

BACKGROUND: Adverse Drug Reactions (ADRs) are an important contributor to patient morbidity and hospitalisation in Uganda. Under-reporting of ADRs may increase medicine-induced morbidity and mortality among patients. This study determined the extent of ADR reporting, and associated factors, among healthcare workers in Uganda.
METHODS: A quantitative, cross-sectional, study was conducted. Pretested, semi-structured questionnaires were administered to 289 randomly sampled healthcare workers over a three-month period in Mulago National Referral Hospital, Uganda. The primary outcome was the proportion of healthcare workers who had ever reported an ADR. Data was double-entered in Epidata version 3.0, cleaned and exported to STATA version 10.1 for analysis.
RESULTS: The overall response rate was 77.2% (n=223). The majority of the respondents were females (139, 62.3%). The median age of all respondents was 32.6 years (min-23; max-65). Only about 16.6% (n=37) of healthcare workers had ever reported an ADR. Very few (n= 84, 37.7%) healthcare workers knew the tools used in ADR reporting. Less than a quarter (n=41, 18.4%) of the healthcare workers knew where to report ADRs. Lack of training was reported as the major (56.5%, 126) deterrent to reporting ADRs by healthcare workers.
CONCLUSION: Adverse drug reactions are under-reported in Uganda, and healthcare workers have insufficient knowledge of existing pharmacovigilance systems, including ADR reporting systems. To address these challenges, there is need to sensitize and train healthcare workers in patient-centred aspects of medicine surveillance, so as to provide appropriate care while optimising patient safety.

Entities:  

Keywords:  ADR; Adverse drug reaction; Uganda; adverse effects; healthcare worker; pharmacovigilance; reporting

Mesh:

Year:  2015        PMID: 26958036      PMCID: PMC4765406          DOI: 10.4314/ahs.v15i4.34

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  17 in total

1.  Prescription-event monitoring and reporting of adverse drug reactions.

Authors:  E Heeley; J Riley; D Layton; L V Wilton; S A Shakir
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

2.  Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting.

Authors:  C F Green; D R Mottram; P H Rowe; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

3.  Attitudes to adverse drug reaction reporting in the Northern Region.

Authors:  D N Bateman; G L Sanders; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

4.  Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.

Authors:  Hasifa Bukirwa; Susan Nayiga; Rosalind Lubanga; Norah Mwebaza; Clare Chandler; Heidi Hopkins; Ambrose O Talisuna; Sarah G Staedke
Journal:  Trop Med Int Health       Date:  2008-07-08       Impact factor: 2.622

5.  Awareness and reporting of adverse drug reactions among health care professionals in Sudan.

Authors:  Asim Ahmed Elnour; Ahmed Dahab Ahmed; Mirghani Abd Elrahman Yousif; Abdulla Shehab
Journal:  Jt Comm J Qual Patient Saf       Date:  2009-06

Review 6.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

7.  Evaluation and pharmacovigilance of projects promoting cultivation and local use of Artemisia annua for malaria.

Authors:  Merlin L Willcox; Shelly Burton; Rosalia Oyweka; Rehema Namyalo; Simon Challand; Keith Lindsey
Journal:  Malar J       Date:  2011-04-11       Impact factor: 2.979

8.  Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.

Authors:  Andrea Kuemmerle; Alex N O Dodoo; Sten Olsson; Jan Van Erps; Christian Burri; Paul S Lalvani
Journal:  Malar J       Date:  2011-03-09       Impact factor: 2.979

9.  Designing adverse event forms for real-world reporting: participatory research in Uganda.

Authors:  Emma C Davies; Clare I R Chandler; Simeon H S Innocent; Charles Kalumuna; Dianne J Terlouw; David G Lalloo; Sarah G Staedke; Ane Haaland
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

10.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Jacob O Awobusuyi
Journal:  BMC Clin Pharmacol       Date:  2009-08-11
View more
  13 in total

1.  Pharmacovigilance and radiologists: How well do they get along?

Authors:  Ozlem Celik Aydin; Sonay Aydin; Hakki Zafer Guney
Journal:  Br J Radiol       Date:  2020-09-09       Impact factor: 3.039

2.  Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria.

Authors:  Theophilus A Adegbuyi; Joseph O Fadare; Ebisola J Araromi; Abayomi O Sijuade; Iyanu Bankole; Ilesanmi K Fasuba; Rachel A Alabi
Journal:  Hosp Pharm       Date:  2020-09-18

3.  The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study.

Authors:  Helen Byomire Ndagije; Leonard Manirakiza; Dan Kajungu; Edward Galiwango; Donna Kusemererwa; Sten Olsson; Anne Spinewine; Niko Speybroeck
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

4.  Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study.

Authors:  Kidu Gidey; Mohammedamin Seifu; Berhane Yohannes Hailu; Solomon Weldegebreal Asgedom; Yirga Legesse Niriayo
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

5.  Knowledge, attitude, practices, and barriers regarding pharmacovigilance and adverse drug reaction reporting among medical and dental faculties of the teaching hospitals in Bhubaneswar City.

Authors:  Avinash Jnaneswar; Suranjana Jonak Hazarika; Kunal Jha; S Vinay; Gunjan Kumar
Journal:  J Educ Health Promot       Date:  2020-10-30

6.  Adverse drug reactions reporting practice and associated factors among community health extension workers in public health facilities, Southwest, Nigeria.

Authors:  Waheed Adeola Adedeji; AbdulKabir Babajide Adegoke; Fatai Adewale Fehintola
Journal:  Pan Afr Med J       Date:  2021-11-17

7.  Adverse Drug Reaction and Its Predictors Among Psychiatric Patients Taking Psychotropic Medications at the Mizan-Tepi University Teaching Hospital.

Authors:  Fikadu Ejeta; Temesgen Aferu; Diriba Feyisa; Oliyad Kebede; Jafer Siraj; Workineh Woldeselassie Hammeso; Esayas Tadesse; Alemayehu Tinishku
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-29       Impact factor: 2.570

8.  Predictors of Medication-Related Emergency Department Admissions Among Patients with Cardiovascular Diseases at Mbarara Regional Referral Hospital, South-Western Uganda.

Authors:  Joshua Kiptoo; Tadele Mekuriya Yadesa; Conrad Muzoora; Juliet Sanyu Namugambe; Robert Tamukong
Journal:  Open Access Emerg Med       Date:  2021-06-29

9.  Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district.

Authors:  H M Haines; J C Meyer; R S Summers; B B Godman
Journal:  Eur J Clin Pharmacol       Date:  2020-04-15       Impact factor: 2.953

10.  Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia.

Authors:  Solomon Shiferaw Nadew; Kidanemariam G/Michael Beyene; Solomon Worku Beza
Journal:  PLoS One       Date:  2020-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.